Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Valuable Targets
6 min read
Advances in Clinical Research on Neuraminidase Inhibitor
1 November 2023
The surface of the influenza virus is distributed with three important proteins, namely, hemagglutinin (HA), neuraminidase (NA), and matrix protein (M2), each playing an important role in the transmission cycle of the influenza virus.
Latest Hotspot
4 min read
Genentech's Vabysmo gets FDA authorization for use in treating Retinal Vein Occlusion (RVO)
31 October 2023
Genentech has communicated that the FDA has given approval for Vabysmo®(faricimab-svoa) to be used in treating macular edema that occurs after retinal vein occlusion.
Drug Insights
4 min read
Deep Scientific Insights on Cefazolin Sodium's R&D Progress, Mechanism of Action, and Drug Target
31 October 2023
This article summarized the latest R&D progress of Cefazolin Sodium, the mechanism of action for Cefazolin Sodium, and the drug target R&D trends for Cefazolin Sodium.
Latest Hotspot
3 min read
Tenaya Therapeutics receives FDA approval to initiate the clinical trial of TN-401 gene therapy for treating PKP2-related Arrhythmogenic Right Ventricular Cardiomyopathy
31 October 2023
Tenaya Therapeutics, a clinical-phase biotech firm focusing on heart disease treatments, announced today they've received FDA approval for their IND application to begin clinical trials for TN-401.
Drug Insights
4 min read
Exploring Camrelizumab's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
31 October 2023
This article summarized the latest R&D progress of Camrelizumab, the Mechanism of Action for Camrelizumab, and the drug target R&D trends for Camrelizumab.
Bio Sequence
2 min read
Biological Glossary | What is Cyclopeptide?
31 October 2023
A cyclopeptide is a type of peptide in which the amino acid sequence forms a cyclic rather than a linear structure.
Latest Hotspot
3 min read
Mustang Bio confirms that FDA has approved the IND application for MB-109, aimed at treating recurrent Glioblastoma and High-Grade Astrocytoma
31 October 2023
Mustang Bio, Inc., a biopharmaceutical firm conducting clinical trials and developing cell and gene therapies for difficult cancers and rare genetic diseases, announced FDA approval of their IND application for MB-109.
Bio Sequence
2 min read
Biological Glossary | What is Conserved Sequence?
31 October 2023
In biology, conserved sequences refer to molecular sequences with high similarity or identity.
Drug Insights
3 min read
Decoding Casirivimab: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
31 October 2023
This article summarized the latest R&D progress of Casirivimab, the Mechanism of Action for Casirivimab, and the drug target R&D trends for Casirivimab.
Bio Sequence
3 min read
Toripalimab: FDA Greenlights First made-in-China PD-1 and Its Evolving Competitive Landscape
31 October 2023
According to the Patsnap Bio Sequence Database, the top 10 applicants for the toripalimab patent are as follows: Shanghai Junshi Biosciences with 52 applications, Cugene with 30 applications, and Guangzhou Zhiyi Biotech with 16 applications. For more applicants, please refer to the image below.
Drug Insights
4 min read
An In-depth Analysis of Cephradine's R&D Progress and Mechanism of Action on Drug Target
30 October 2023
This article summarized the latest R&D progress of Cephradine, the Mechanism of Action for Cephradine, and the drug target R&D trends for Cephradine.
Latest Hotspot
3 min read
CSPC Pharmaceutical Group's Claudin6/CD137 Dual Antibody NBL-028 has been approved for clinical trials, aimed at treating late-stage solid tumors
30 October 2023
Recently, CSPC Pharmaceutical announced that its independently developed bispecific antibody targeting Claudin6/CD137, NBL-028, has received approval from the National Medical Products Administration (NMPA) in China for clinical trial applications.